Merck’s COVID pill fails to prevent infection among household members – ET HealthWorld
Bengaluru: Merck & Co Inc said on Tuesday its COVID-19 pill was not effective at cutting the risk of coronavirus…
Fast News Hear
Bengaluru: Merck & Co Inc said on Tuesday its COVID-19 pill was not effective at cutting the risk of coronavirus…
Exclusive Molnupiravir, developed by Merck which is also known as MSD outside the United States and Canada, is approved to…
London: Using the antiviral drug molnupiravir does not decrease deaths or hospital admissions among Covid-19 patients who are vaccinated and…
By Natalie Grover LONDON, – Merck & Co Inc’s COVID antiviral molnupiravir speeds up recovery but does not reduce the…
Experts from the Indian Council of Medical Research (ICMR) have not found a compelling reason to include Pfizer’s antiviral drug…
MUMBAI: During the two years of the pandemic, there were sky-rocketing sales of Covid-19 portfolio of drugs, sometimes even severe…
by Dr. P P Bose The COVID-19 pandemic has brought a lot of uncertainties and new challenges in the lives…
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19…
The much-hailed anti-viral drug Molnupiravir is expected to work against the highly contagious Omicron as other variants of concern and…
Mumbai: Molnupiravir, the first oral antiviral for treatment of mild to moderate Covid approved by the US Food and Drug…